Breaks Categories: News

FridayJun 28, 2024 11:01 am

NetworkNewsBreaks – DigiAsia Corp. (NASDAQ: FAAS) Closes on $3.6M Private Placement

DigiAsia (NASDAQ: FAAS), a leading Fintech as a Service (“FaaS”) ecosystem provider, has entered into a Securities Purchase Agreement (“SPA”) with a group of investors. According to the agreement, DigiAsia will sell certain Class A convertible promissory notes and Class B convertible promissory notes as well as warrants. The notes, which have a one-year maturity, total up to $8,863,528.24. Each warrant will be a five-year warrant for a number of ordinary shares equal to the principal amount of the Class A note issued to the applicable investor, multiplied by 60% and divided by 120% of the closing price of the ordinary…

Continue Reading

FridayJun 28, 2024 10:55 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced that the United States District Court for the Eastern District of Pennsylvania ruled in favor of FSD Pharma and is granted its motion for entry of judgment against Dr. Raza Bokhari, the company’s former CEO. The decision awards FSD Pharma several awards, including $147,301.04 plus interest at a rate of 4% per annum from Nov. 9, 2022, until the date the judgment is satisfied; C$31,912.55 plus interest at a rate…

Continue Reading

FridayJun 28, 2024 10:34 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Hosts British Columbia Government Officials at Its Quantum Engineering Center of Excellence

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, announced that Jagrup Brar, British Columbia (“B.C.”) Minister of State for Trade and Member of Legislative Assembly (“MLA”) for Surrey-Fleetwood, and Janet Routledge, B.C. Parliamentary Secretary for Labour and MLA for Burnaby North, toured the company’s Burnaby-based Quantum Engineering Center of Excellence. According to the announcement, the visit was intended to help inform the B.C. government officials about D-Wave’s latest quantum computing product developments and efforts to spur quantum adoption around the world. In conjunction with…

Continue Reading

FridayJun 28, 2024 9:51 am

NetworkNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Stock Sees Uptick Following SEC Approval

Trump Media & Technology Group (NASDAQ: DJT) has recently seen a notable uptick in its stock value, marking a 23% increase that has helped recover some of its earlier losses. This surge is directly tied to the SEC’s green light for the company to register more shares, a move that not only allows early investors to sell off some of their holdings but also to act on stock warrants. These warrants let investors buy more shares at a set price before a certain date. With this approval, Trump Media is set to gain nearly $70 million from these transactions. The company,…

Continue Reading

ThursdayJun 27, 2024 3:42 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Notes ‘Important Step’ as Phase 1 Lucid-21-302 Trial Receives HREC Approval

  FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has received a key approval for its planned Lucid-21-302 trial. According to the announcement, the human ethics review committee (“HREC”) in Australia approved the trial, which is titled “A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.” A first-in-class, nonimmunomodulatory, neuroprotective compound, Lucid-21-302 offers a unique mechanism of action for the treatment of multiple sclerosis (“MS”). “After much…

Continue Reading

ThursdayJun 27, 2024 2:15 pm

NetworkNewsBreaks – Digital Ally Inc. (NASDAQ: DGLY) Closes on Approximately $2.9M Private Placement

  Digital Ally (NASDAQ: DGLY) is a leading provider of video solutions that develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and event security. The company recently announced the closing of a private placement with certain institutional investors. The transactions resulted in aggregate gross cash proceeds of approximately $2.9 million before deductions. Digital Ally intends to use the net proceeds from the private placement for inventory purchases, artist costs for upcoming festivals, transaction cost, expanded sales, marketing and general working capital. The company issued an aggregate of 1,195,219…

Continue Reading

ThursdayJun 27, 2024 1:35 pm

NetworkNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Strengthens Financial Position with $15M Financing Transactions

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, today announced the successful restructuring of $8 million of its debt. The debt was due this month. The company also stated that it has secured an additional $2 million in debt financing. Additionally, key shareholders have exercised warrants at an exercise price of $0.90 per share, resulting in an additional $5 million in capital. The company expects these financing transactions to help it further enhance its product offerings, advance its Secure Data Fabric (“SDF”) roadmap, and drive forward growth in the cybersecurity space. “We…

Continue Reading

ThursdayJun 27, 2024 12:27 pm

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Subsidiary Provides Key Robotic Solutions for Hospitality Labor Challenges

  Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, and its new subsidiary, Future Hospitality Ventures Holdings, Inc. ("Future Hospitality"), offer game-changing plug-and-play robotics and automation solutions that solve hospitality labor issues. Using the Robots-as-a-Service (“RaaS”) business model, Future Hospitality provides two robotics solutions designed to transform both front-end and back-end operations within the hospitality industry. The serving robot is an advanced solution that works with wait staff to ensure faster, more reliable service on the front end, helping streamline service delivery, minimize wait times and reduce human errors. On the back end, Future Hospitality’s smart cooking…

Continue Reading

ThursdayJun 27, 2024 11:40 am

NetworkNewsBreaks – Rivian Automotive Inc. (NASDAQ: RIVN) Sees Stock Soar After Volkswagen Investment

  Rivian Automotive (NASDAQ: RIVN), a key player in the electric vehicle market, recently saw its stock price soar following a significant announcement. The company, known for its innovative approach to EVs, caught the market’s attention with news of a substantial $5 billion investment from Volkswagen. This investment not only infuses Rivian with considerable financial resources but also marks the start of a promising joint venture aimed at pushing the boundaries of electric vehicle technology. The collaboration between Rivian and Volkswagen is set to focus on the development of new technologies for electric vehicles. This partnership is a clear indication…

Continue Reading

ThursdayJun 27, 2024 9:35 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Filing of Provisional Patent Covering Manufacturing Process of New Solid Forms of Buntanetap

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), is announcing the filing of a provisional patent. This patent covers the manufacturing process of new solid forms of buntanetap (formerly known as Posiphen or ANVS401), which targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins. According to the announcement, the patent encompasses the methods for manufacturing the new crystalline form of buntanetap (CAS# 3032752-92-1) as well as the entire synthesis process, from basic starting materials to finished (>99.9% pure) GMP product, suitable for manufacturing scale at ton…

Continue Reading